Background: Systemic lupus erythematosus in children (Paediatric SLE / pSLE) 
regarding the presentation of pSLE in the country. The present study is an extension of 2008 case series including cases up to December 2013. Objectives of this study were to evaluate the clinical and serological presentation of pSLE in a tertiary referral hospital of Bangladesh and to compare it with those in other populations.
Methodology:
It was a retrospective study carried out in the Department of Paediatrics, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka.
All the patients attending the paediatric rheumatology follow up clinic and paediatric ward during the period of January 2005 of December 2013 were included in the study.
The Department of Paediatrics has been running a paediatric rheumatology clinic twice a week since the year 2000, which is the only paediatric rheumatology clinic in the country. Since 2005 this clinic has been running in a more organized way and all the case records are preserved. Patients attend this clinic from different parts of the country. Before visiting the clinic, most of the patients visited other hospitals or clinicians including GPs, paediatricians and adult physicians.
Patients who fulfilled 4 or more criteria of the 1997 revised American College of Rheumatology (ACR) classification criteria for SLE, either at presentation or sequentially were considered as SLE. 1 Children below the age of 16 years from both the sexes fulfilling the ACR criteria were included in the study.
All the case records were reviewed by two trained paediatric rheumatologists. Age, gender and clinical features at initial diagnosis were recorded in a data collection from. Laboratory investigations in addition to immunological and pathological findings at diagnosis were also recorded. Laboratory investigations included urinary, haematological and radiological findings. The immunological parameters included antinuclear antibodies (ANA), anti dsDNA, C 3 and C 4. ANA was determined by immunofluorescence technique using Hep-2 cells as substrate. Anti-double stranded DNA (Anti-ds DNA) was measured by ELISA method. Complements were measured by nephlometry.
Histopathological evaluation of kidney biopsy specimen in patients with lupus nephritis was done. The renal histopathology was classified according to modified World Health Organization (WHO) classification 9 .
The clinical features that were recorded included constitutional symptoms such as fever, general weakness, cutaneous, mucosal, articular, renal, CNS manifestations, generalized lymphadenopathy and hepatosplenomegaly. Urine analysis and urinary total protein (UTP) were also recorded.
Auto-immune hemolytic anemia was diagnosed by positive Coomb's test. Leucocytopaenia was considered when total WBC count was less than 4000/ cmm. Similarly thrombocytopenia (<1000, 000/m 3 ) in the absence of any offending drugs, proteinuria (0.5g/24 hrs or more), hematuria (>5 RBC/HPF) were recorded. Pleural effusion and pericardial effusion were documented by positive clinical findings as well as radiological and echo-cardiographic findings.
All the data were tabulated and calculated manually. Results were expressed as mean, standard deviation, range and frequency.
Results:
A total of 70 patients were enrolled in the study. Age range at diagnosis was 2.5 years to 16 years, mean age being 11.6 years. Female: male ratio was 7:1. Duration of disease at presentation was 1 month to 18 months, mean being 09.5 months.
General weakness or fatigue (91%), fever (83%), arthralgia/arthritis (74%), oral ulcer (73%) and skin rash (71%) were most common clinical features at disease onset (Table-I) . When laboratory findings were analyzed, 100% patients were found to have anemia (hemoglobin range: 4.4-10.2mg/dl; mean 8.5mg/dl). Auto immune hemolytic anemia was found in 16% patients. Thrombocytopenia and leucocytopenia was present in 17% and 10% patients respectively. Urinary total protein was high in 59% cases. ANA was positive in 97% and Anti ds DNA in 91% cases. Low C3 and C4 were found in 83% and 84% patients respectively ( Table-II) . Twenty six percent of our SLE patients had neuropsychiatric manifestations at presentation. Pulmonary and cardiac involvement was present in 10% and 06% cases respectively ( Table-IV) .
The clinical and laboratory findings of childhood SLE patients from Bangladesh are compared to other childhood SLE series from India, Philippines, Oman, France, Europe and Egypt. The comparison is shown in Table- IV. 
Discussion:
This retrospective cohort study was carried out with the objective of describing the presentation of childhood SLE cases in Bangladesh and comparing it with some other published reports.
We studied the clinical and serological presentation of 70 childhood SLE cases of Bangladesh for the first time and compared the clinical presentation with the childhood SLE series of other countries to identify any variations. As it was performed in a tertiary referral hospital, the study may not represent all the cases of childhood SLE in Bangladesh. It may however give an insight about these patients.
In our series, mean age at diagnosis was 11.62 (SD 2.6) years, which was comparable to other studies (Table 4 ). Age range of our series was 2.5 years to 16 years. Upper age limit (16 years) was comparable to other studies but lower age limit was variable in different studies. Female preponderance, similar with other reports, may be due to the importance of hormonal factors in the clinical expression of the disease.
General weakness/fatigue was the most common clinical presentation (91%) in this series followed by fever (83%). Constitutional symptoms such as fatigue, fever and weight loss are reported to be very common presentation of childhood SLE1 10 . This fact was also supported by the study.
Arthralgia or arthritis was present in 74% and skin rash (malar rash and non specific rash) in 71% children. Kumar et al in their study found fever as the commonest clinical feature at presentation (75%) followed by Musculo-skeletal (MSK) problems (65%) in India 11 . On the other hand Gulay et al in Philippines found malar rash as the most common (65.3%) presentation in their series 12 . Studies done in Oman 13 and France 14 found musculo-skeletal (76% and 64%) and cutaneous problems (70%) as common presentations, whereas a multi-centered study done in Europe found fatigue as the most common (78.6%) presentation 15 . Bakr A et al in their study done in Egypt 16 found fever and musculo-skeletal problems (77% and 65%) as common presentations.
In the current series 100% of the patients had anaemia (ranging from mild to severe). In Indian series 80% had anaemia 11 . Sixteen percent of our SLE patients had (Coomb's positive) autoimmune haemolytic anaemia which is almost similar to the Indian 11 This study found that 66% of pSLE patients had renal involvement at presentation which was in concordance with the Filipino 12 , Omani 13 and European studies 15 but lower than Egyptian 16 and higher than Indian 11 and French 14 studies. Among the patients who underwent renal biopsy, 40% in this series had Class IV, followed by class III nephritis (WHO). Gulay et al in their Filipino study found similar findings 12 . Reports of nephritis among these compared studies were highest in Egypt (81%) 16 and lowest in France (50%) 14 . These diverse presentations appear to be multifactorial. It is reported that socioeconomic, environmental, demographic, psychosocial and genetic factors may play an important role as determinants of ethnic differences in clinical manifestations of SLE patients 17 .
It is important to mention here that, many of the nephritic presentation cases of childhood SLE including renal failure might have gone to the nephrologists for their management and were not included in this series. This would perhaps introduce a bias in the type of patients seen by our group. It may be possible that percentage of renal involvement of pSLE cases in our country may be even higher than what we have found.
The second most common organ involvement at presentation in our series was neuropsychiatric involvement (26%). This was almost in concordance with other compared studies [11] [12] [13] [14] [15] [16] . Our patients had relatively much lower cardiac (06%) and pulmonary (10%) involvements. The reasons for this lower rate of involvements are not clear. But it may be possible that, echocardiogram or chest CT scans in this study was performed only on the symptomatic SLE patients. If these investigations could have been done to all the studied patients, percentage of cardiac and pulmonary involvement could have gone higher.
ANA positivity was 97%in our study. This finding was almost similar with Gulay et al 12 and Bakr A study 16 . Low C3 was found in 83% of our cases which was almost similar with Bakr A study 14 but much higher than Gulay et al study 12 .
Few studies are done comparing the clinical presentation of childhood and adult SLE. Renal and haematologic abnormalities were more common at presentation in one comparative study 18 . Another multiethnic disease cohort showed that childhood SLE had significantly more renal and neurological involvement at the time of entry into the study. Pediatric patients also had more active disease at diagnosis, as measured by valid disease activity measure 19 . Joseph et al in their study showed that nephropathy, fever, and lymphadenopathy were more common in childhood onset SLE patients 20 . The present study also found very high incidence of fever, renal involvement and neuropsychiatric involvement among pediatric SLE patients along with non-specific clinical manifestations.
Conclusion:
This study emphasizes that childhood SLE can present with non-specific and protean clinical manifestations. A high index of suspicion is very much needed for diagnosing pSLE. SLE should be excluded in cases of pyrexia of unknown origin (PUO) and nonspecific general weakness in patients especially in adolescent girls where no specific causes are present. At presentation, our patients had some similarities as well as some differences compared to previous reports from different countries. Further study with a large sample size including both hospitals and community is needed to draw a definite conclusion.
